WHY HAVE NEW EFFECTIVE THERAPIES FOR SEPSIS NOT BEEN DEVELOPED

被引:38
作者
EIDELMAN, LA [1 ]
SPRUNG, CL [1 ]
机构
[1] HEBREW UNIV JERUSALEM, HADASSAH MED CTR, DEPT ANESTHESIOL & CRIT CARE MED, IL-91120 JERUSALEM, ISRAEL
关键词
SEPSIS; SHOCK; TREATMENT; CRITICAL ILLNESS; CLINICAL TRIALS; ENDOTOXIN; CYTOKINES;
D O I
10.1097/00003246-199408000-00018
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:1330 / 1334
页数:5
相关论文
共 34 条
[21]   THE ETHICS OF THE RANDOMIZED CLINICAL-TRIAL [J].
SCHAFER, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (12) :721-724
[22]  
Shapiro L, 1993, New Horiz, V1, P13
[23]  
SIEGEL JP, 1992, NEW ENGL J MED, V327, P890
[24]   THE EFFECTS OF HIGH-DOSE CORTICOSTEROIDS IN PATIENTS WITH SEPTIC SHOCK - A PROSPECTIVE, CONTROLLED-STUDY [J].
SPRUNG, CL ;
CARALIS, PV ;
MARCIAL, EH ;
PIERCE, M ;
GELBARD, MA ;
LONG, WM ;
DUNCAN, RC ;
TENDLER, MD ;
KARPF, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (18) :1137-1143
[25]   THE EFFECT OF ANESTHETIC AGENTS ON THE HUMAN IMMUNE-RESPONSE [J].
STEVENSON, GW ;
HALL, SC ;
RUDNICK, S ;
SELENY, FL ;
STEVENSON, HC .
ANESTHESIOLOGY, 1990, 72 (03) :542-552
[26]   PROTECTION AGAINST GRAM-NEGATIVE BACTEREMIA AND ENDOTOXEMIA WITH HUMAN MONOCLONAL IGM ANTIBODIES [J].
TENG, NNH ;
KAPLAN, HS ;
HEBERT, JM ;
MOORE, C ;
DOUGLAS, H ;
WUNDERLICH, A ;
BRAUDE, AI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1790-1794
[27]   ANTI-CACHECTIN TNF MONOCLONAL-ANTIBODIES PREVENT SEPTIC SHOCK DURING LETHAL BACTEREMIA [J].
TRACEY, KJ ;
FONG, Y ;
HESSE, DG ;
MANOGUE, KR ;
LEE, AT ;
KUO, GC ;
LOWRY, SF ;
CERAMI, A .
NATURE, 1987, 330 (6149) :662-664
[28]   SEPSIS, SEVERE SEPSIS OR SEPSIS SYNDROME - NEED FOR CLARIFICATION [J].
VINCENT, JL ;
BIHARI, D .
INTENSIVE CARE MEDICINE, 1992, 18 (05) :255-257
[29]   CLINICAL TRIAL DESIGN IN STUDIES OF CORTICOSTEROIDS FOR BACTERIAL INFECTIONS [J].
WEITZMAN, S ;
BERGER, S .
ANNALS OF INTERNAL MEDICINE, 1974, 81 (01) :36-42
[30]  
WHERRY J, 1993, 33RD INT C ANT AG CH